Revenue | $100 - $500 million See Exact Annual Revenue |
---|---|
Employees | 500 - 1,000Exact Company Size |
Primary Industry | 5417 Scientific Research & Development Services |
Additional NAICS Codes | 541711 Research & Development in Biotechnology 541714 |
Address | Suite 200 1551, Eastlake Avenue East Seattle, WA 98102 adaptivebiotech.com |
Adaptive Biotechnologies | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Date | Investors | Percent Raised | Target Size |
---|---|---|---|
May 11, 2015 | 16 | 100% | $195 MM |
Complete list of funding rounds and total amounts in the Company Report |
$ Millions (Industry Average) | |
---|---|
Adaptive Biotechnologies Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
T-DETECT Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use , namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection | 06/03/2022 |
T T-DETECT Medical assay kits comprised of diagnostic reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, autoimmune disease and infection; medical immunosequencing-based assay kits comprised of diagnostic reagents for medical use; medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection | 01/22/2021 |
Publisher: AnythingResearch
Company | Headquarters | Revenue ($ MM) |
---|---|---|
LEIDOS | Reston, VA | 100 |
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 31 |
INC RESEARCH | Raleigh, NC | 28 |
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
ILLUMINA | San Diego, CA | 13 |
UT-BATTELLE | Oak Ridge, TN | 12 |
PRA HOLDINGS | Raleigh, NC | 12 |
BATTELLE ENERGY ALLIANCE | Idaho Falls, ID | 11 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
FRED HUTCHINSON CANCER CENTER | Seattle, WA | 100 |
ADAPTIVE BIOTECHNOLOGIES | Seattle, WA | 14 |
ALLEN INSTITUTE | Seattle, WA | 13 |
SANA BIOTECHNOLOGY | Seattle, WA | 9 |
ULTRA SAFE NUCLEAR | Seattle, WA | 5 |
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | Seattle, WA | 5 |
Company | Revenue ($ MM) |
---|---|
|